BGiordano
TL2 Member · Salzburg, AT
Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.
Joined 24 September 2024 · last posted 2d
80 posts, newest first. Showing up to 150.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #28 · Compounds › Oral incretins · 26 Jul 2026 · 2 likes post #27 is right about the mechanism and I think understates the practical bit. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Common supplements people ask about, assessed one at a time Replied, post #94 · Practice › Interactions · 25 Jul 2026 · 24 likes Worth separating two things that post #90 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #68 · Start Here › Welcome · 21 Jul 2026 · 32 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #95 · Evidence › Journal club · 21 Jul 2026 · 0 likes On post #91 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #22 · Analytics › Mass spectrometry · 19 Jul 2026 · 0 likes Worth separating two things that post #18 runs together. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #83 · Wellbeing › Sleep · 12 Jul 2026 · 1 like post #82 is right about the mechanism and I think understates the practical bit. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #39 · Evidence › Trials · 8 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #19 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #32 · Practice › Dosing & titration · 2 Jul 2026 · 6 likes post #31 is right about the mechanism and I think understates the practical bit. How the published trials escalated: they used specific step sizes and intervals. The…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #87 · Start Here › How to Ask · 1 Jul 2026 · 24 likes Picking up post #84: that is the part I would want checked first. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #89 · Compounds › Semaglutide · 29 Jun 2026 · 10 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Athletes in weight-category sports: a different risk calculus Replied, post #5 · Clinical › Special populations · 27 Jun 2026 · 1 like Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #21 · Compounds › Semaglutide · 18 Jun 2026 · 1 like Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #97 · Sourcing › Logistics · 10 Jun 2026 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #39 · Analytics › Method validation · 1 Jun 2026 · 4 likes Coming back to post #37, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A checklist for reading a certificate in under two minutes Replied, post #31 · Analytics › COA interpretation · 31 May 2026 · 7 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Follow-up: Prior authorisation: what the criteria usually require Started this topic · Access › Insurance & coverage · 29 May 2026 · 41 likes Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #6 · Devices › Syringes & needles · 24 May 2026 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #24 · Compounds › Repair & healing peptides · 12 May 2026 · 23 likes On post #20 — agreed on the reasoning, with one qualification. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #5 · Compounds › Retatrutide · 11 May 2026 · 15 likes post #4 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #32 · Practice › Administration · 26 Apr 2026 · 19 likes post #31 is right about the mechanism and I think understates the practical bit. A genuinely late dose: the labelling generally says that if the next dose is more than…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #5 · Evidence › Journal club · 18 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Splitting an overlong document into two Replied, post #13 · Documentation › Wiki requests · 14 Apr 2026 · 15 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #69 · Analytics › Mass spectrometry · 10 Apr 2026 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #65 · Practice › Administration · 7 Apr 2026 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Why the timeline is on the right and not the left — what changed since Replied, post #16 · Meta › Site feedback · 6 Apr 2026 · 2 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
The "under review" status pill and when a moderator applies it Replied, post #34 · Evidence › Preprints · 23 Mar 2026 · 0 likes Picking up post #31: that is the part I would want checked first. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #6 · Analytics › Mass spectrometry · 11 Feb 2026 · 0 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Trifluoroacetate content and its consequences Replied, post #89 · Analytics › Impurities & related substances · 5 Feb 2026 · 7 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Recording a dissent on a document rather than suppressing it Replied, post #3 · marked as the solution · Documentation › Doc review · 28 Jan 2026 · 7 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #8 · Compounds › Semaglutide · 16 Jan 2026 · 32 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Jan 2026 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #75 · Compounds › Tirzepatide · 11 Dec 2025 · 3 likes I read post #73 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Guidelines revision: what changed and why — one year on Replied, post #44 · Meta › Announcements · 8 Dec 2025 · 1 like Worth separating two things that post #40 runs together. Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #62 · Compounds › Semaglutide · 5 Dec 2025 · 0 likes This follows post #59 rather than contradicting it. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #77 · Practice › Reconstitution · 26 Nov 2025 · 4 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #7 · Compounds › Tirzepatide · 25 Nov 2025 · 6 likes post #6 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #14 · Sourcing › Regulatory · 3 Nov 2025 · 25 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
EMA product information as a primary source Replied, post #5 · Regional › European Union · 26 Oct 2025 · 0 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Which panel is worth repeating and which is worth ignoring Replied, post #131 · Clinical › Bloodwork · 7 Oct 2025 · 1 like I read post #129 twice before replying, because I had assumed the opposite. Biological variation: the person-to-person variation in a biomarker for a healthy person is…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Started this topic · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 0 likes Cagrilintide's dosing interval and the pharmacokinetics behind it — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #11 · Analytics › Home & field testing · 13 Sep 2025 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Documenting an adverse event properly Replied, post #4 · Safety › Adverse events · 11 Sep 2025 · 16 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #17 · Devices › Pens & autoinjectors · 3 Sep 2025 · 0 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #35 · Evidence › Journal club · 21 Aug 2025 · 26 likes Worth separating two things that post #31 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
What this community means by "a source", in practical terms Replied, post #68 · Start Here › Welcome · 12 Aug 2025 · 17 likes I read post #66 twice before replying, because I had assumed the opposite. The moderation log is public. Every staff action is logged with the rule cited and the…
-
Warfarin and altered intake: the monitoring argument — the long version Started this topic · Practice › Interactions · 3 Aug 2025 · 9 likes Posting this under the heading it deserves: Warfarin and altered intake: the monitoring argument — the long version Everything below is what sits behind that. Reporting…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 26 likes On post #67 — agreed on the reasoning, with one qualification. Cagrilintide alone is discussed less than in combination because the published data is almost entirely…
-
Sodium, potassium and magnesium when intake drops Replied, post #31 · Nutrition & Training › Hydration & electrolytes · 26 Jun 2025 · 1 like The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #7 · Practice › Reconstitution · 3 Jun 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Half-life, steady state, and accumulation worked through Replied, post #40 · Pharmacology › Pharmacokinetics · 30 May 2025 · 14 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Pregnancy as an absolute contraindication Replied, post #77 · Safety › Contraindications · 20 May 2025 · 0 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #32 · Evidence › Journal club · 14 May 2025 · 23 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #96 · Access › Pricing · 11 May 2025 · 19 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Scheduled maintenance and what will be unavailable Replied, post #129 · Meta › Announcements · 30 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Requesting a translation of an existing page Replied, post #9 · Documentation › Wiki requests · 15 Apr 2025 · 21 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Carryover and the ghost peak from last week's standard Replied, post #81 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 18 likes Picking up post #78: that is the part I would want checked first. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher…
-
Ipamorelin selectivity claims and where they came from Replied, post #26 · Compounds › Secretagogues & GH axis · 5 Apr 2025 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #6 · Start Here › Welcome · 22 Mar 2025 · 7 likes Coming back to post #4, because the follow-up matters more than the original answer. On the reading order question specifically: start with the how-to-ask materials in…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #47 · Compounds › Semaglutide · 21 Mar 2025 · 4 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Validating a method you did not develop — does this still hold? Replied, post #79 · Analytics › Method validation · 6 Mar 2025 · 1 like Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2025 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: What published stability data actually covers, and what it does not Started this topic · Practice › Storage & stability · 1 Mar 2025 · 36 likes The question in the title: What published stability data actually covers, and what it does not I will give what I have already checked below so nobody repeats it.…
-
Validating a method you did not develop — does this still hold? Replied, post #31 · Analytics › Method validation · 21 Feb 2025 · 26 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #36 · Practice › Reconstitution · 19 Feb 2025 · 19 likes This follows post #33 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
When to suspect the method rather than the sample Replied, post #84 · Analytics › Method validation · 18 Feb 2025 · 23 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Consistent declarations and why they matter more than clever ones Replied, post #45 · Sourcing › Logistics · 17 Feb 2025 · 1 like Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #47 · Devices › Cold chain · 5 Feb 2025 · 0 likes I read post #45 twice before replying, because I had assumed the opposite. Assessing an excursion: if a package sat at room temperature for a time, visual inspection…
-
What changed in 2026, by region Replied, post #110 · Access › International · 30 Jan 2025 · 0 likes post #109 is right about the mechanism and I think understates the practical bit. Regulatory position dates: a regulatory position is only current as of when it was…
-
Protein density versus volume when you cannot eat much Replied, post #30 · Nutrition & Training › Protein & intake · 28 Jan 2025 · 5 likes Worth separating two things that post #26 runs together. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #7 · Compounds › Tirzepatide · 26 Jan 2025 · 23 likes On post #3 — agreed on the reasoning, with one qualification. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #8 · Compounds › Oral incretins · 25 Dec 2024 · 32 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
EMA product information as a primary source — does this still hold? Replied, post #42 · Regional › European Union · 16 Nov 2024 · 0 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #36 · Compounds › Tirzepatide · 14 Nov 2024 · 15 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #88 · Compounds › Other compounds · 2 Nov 2024 · 20 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Promotion criteria, and the one that stops most nominations Replied, post #83 · Documentation › Doc review · 11 Oct 2024 · 15 likes I read post #81 twice before replying, because I had assumed the opposite. Citation checking: if a maintained page cites a paper, the citation should match what the…
-
Chronic kidney disease and the FLOW result Replied, post #39 · Clinical › Comorbidities · 23 Aug 2024 · 12 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Blind submission and why it changes minds Replied, post #21 · Sourcing › Independent verification · 24 Jul 2024 · 16 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #66 · Practice › Dosing & titration · 8 Jul 2024 · 3 likes Coming back to post #64, because the follow-up matters more than the original answer. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #16 · Practice › Dosing & titration · 8 Jun 2024 · 20 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…